Logo
x

Search

Subscribe Now

Poseida Therapeutics

Poseida Therapeutics to Feature Non-Clinical Data of P-KLKB1-101 for Treating Hereditary Angioedema at ACAAI 2024

Poseida Therapeutics to Feature Non-Clinical Data of P-KLKB1-101 for Treating Hereditary Angioedema at ACAAI 2024

  • October 25, 2024
Poseida Therapeutics Nominates a New CAR-T Development Candidate Under Partnership with Roche

Poseida Therapeutics Nominates a New CAR-T Development Candidate Under Partnership with Roche

  • October 18, 2024
Poseida Therapeutics’ P-BCMA-ALLO1 Gains the US FDA’s Regenerative Medicine Advanced Therapy Designation for R/R Multiple Myeloma

Poseida Therapeutics’ P-BCMA-ALLO1 Gains the US FDA’s Regenerative Medicine Advanced Therapy Designation for R/R Multiple Myeloma

  • September 17, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.